Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
Condition(s):Schizophrenia; Schizophrenia RelapseLast Updated:September 15, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Schizophrenia; Schizophrenia RelapseLast Updated:September 15, 2023Recruiting
Condition(s):Schizophrenia; Treatment-resistant Schizophrenia; Side Effect; Lipid Metabolism Disorders; Diabetes; NAFLD; PsychosisLast Updated:September 29, 2023Not yet recruiting
Condition(s):Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis); Schizophrenia and Related Disorders; Stimulant Dependence; Stimulant Abuse; PharmacotherapyLast Updated:July 5, 2023Recruiting
Condition(s):Schizophrenia; Psychosis; Mania; Pregnancy; Drug Exposure in Utero; Drug Exposure Via Breast Milk; Antipsychotic Agents; BreastfeedingLast Updated:December 27, 2023Recruiting
Condition(s):Treatment-resistant SchizophreniaLast Updated:October 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.